These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 28699494)

  • 1. The Small Molecules Targeting Ubiquitin-Proteasome System for Cancer Therapy.
    Ao N; Chen Q; Liu G
    Comb Chem High Throughput Screen; 2017; 20(5):403-413. PubMed ID: 28699494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the ubiquitin proteasome system in haematological malignancies.
    Crawford LJ; Irvine AE
    Blood Rev; 2013 Nov; 27(6):297-304. PubMed ID: 24183816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin-proteasome system as a target for anticancer treatment-an update.
    Kim YJ; Lee Y; Shin H; Hwang S; Park J; Song EJ
    Arch Pharm Res; 2023 Jul; 46(7):573-597. PubMed ID: 37541992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Search for Inhibitors of the Ubiquitin-Proteasome System from Natural Sources for Cancer Therapy.
    Tsukamoto S
    Chem Pharm Bull (Tokyo); 2016; 64(2):112-8. PubMed ID: 26833439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system.
    Buckley DL; Crews CM
    Angew Chem Int Ed Engl; 2014 Feb; 53(9):2312-30. PubMed ID: 24459094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ubiquitin-Proteasome Pathway and Epigenetic Modifications in Cancer.
    Yerlikaya A; Kanbur E; Stanley BA; Tümer E
    Anticancer Agents Med Chem; 2021; 21(1):20-32. PubMed ID: 32781973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Deubiquitinating Enzymes and Autophagy in Cancer.
    Mooneyham A; Bazzaro M
    Methods Mol Biol; 2017; 1513():49-59. PubMed ID: 27807830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future.
    Dalla Via L; Nardon C; Fregona D
    Future Med Chem; 2012 Mar; 4(4):525-43. PubMed ID: 22416778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A patent review of the ubiquitin ligase system: 2015-2018.
    Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
    Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin-proteasome system (UPS) as a target for anticancer treatment.
    Park J; Cho J; Song EJ
    Arch Pharm Res; 2020 Nov; 43(11):1144-1161. PubMed ID: 33165832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the ubiquitin-proteasome system by an NQO1-activatable compound.
    Giovannucci TA; Salomons FA; Haraldsson M; Elfman LHM; Wickström M; Young P; Lundbäck T; Eirich J; Altun M; Jafari R; Gustavsson AL; Johnsen JI; Dantuma NP
    Cell Death Dis; 2021 Oct; 12(10):914. PubMed ID: 34615851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the ubiquitin+proteasome system in solid tumors.
    Driscoll JJ; Woodle ES
    Semin Hematol; 2012 Jul; 49(3):277-83. PubMed ID: 22726552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitination and deubiquitination: Implications on cancer therapy.
    Dagar G; Kumar R; Yadav KK; Singh M; Pandita TK
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194979. PubMed ID: 37633647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A High-Content Screening Assay for the Discovery of Novel Proteasome Inhibitors from Formosan Soft Corals.
    Ling XH; Wang SK; Huang YH; Huang MJ; Duh CY
    Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30347865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of inhibitors in the ubiquitination cascade.
    Zhang W; Sidhu SS
    FEBS Lett; 2014 Jan; 588(2):356-67. PubMed ID: 24239534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lead discovery and chemical biology approaches targeting the ubiquitin proteasome system.
    Akinjiyan FA; Carbonneau S; Ross NT
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4589-4596. PubMed ID: 28911816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Patents on Proteasome Inhibitors of Natural Origin.
    da Silva DC; Andrade PB; Ribeiro V; Valentao P; Pereira DM
    Recent Pat Anticancer Drug Discov; 2017; 12(1):4-15. PubMed ID: 27881056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the ubiquitin proteasome system: beyond proteasome inhibition.
    Xolalpa W; Perez-Galan P; Rodríguez MS; Roué G
    Curr Pharm Des; 2013; 19(22):4053-93. PubMed ID: 23181575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of ubiquitin proteasome pathway in cancer development.
    Yerlikaya A; Yöntem M
    Recent Pat Anticancer Drug Discov; 2013 Sep; 8(3):298-309. PubMed ID: 23061719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin-proteasome system.
    Nandi D; Tahiliani P; Kumar A; Chandu D
    J Biosci; 2006 Mar; 31(1):137-55. PubMed ID: 16595883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.